Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Biomed Res Int ; 2018: 4658106, 2018.
Article in English | MEDLINE | ID: mdl-29511681

ABSTRACT

BACKGROUND: In 2005, Nigeria changed its policy on prevention of malaria in pregnancy to intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP). Indicators of impact of effective prevention and control of malaria on pregnancy (MIP) are low birth weight (LBW) and maternal anaemia by parity. This study determined the prevalence of LBW for different gravidity groups during periods of pre- and postpolicy change to IPTp-SP. METHODS: Eleven-year data were abstracted from the delivery registers of two hospitals. Study outcomes calculated for both pre- (2000-2004) and post-IPTp-SP-policy (2005-2010) years were prevalence of LBW for different gravidity groups and risk of LBW in primigravidae compared to multigravidae. RESULTS: Out of the 11,496 singleton deliveries recorded within the 11-year period, the prevalence of LBW was significantly higher in primigravidae than in multigravidae for both prepolicy (6.3% versus 4%) and postpolicy (8.6% versus 5.1%) years. The risk of LBW in primigravidae compared to multigravidae increased from 1.62 (1.17-2.23) in the prepolicy years to 1.74 (1.436-2.13) during the postpolicy years. CONCLUSION: The study demonstrated that both the prevalence and risk of LBW remained significantly higher in primigravidae even after the change in policy to IPTp-SP.


Subject(s)
Gravidity/physiology , Infant, Low Birth Weight , Malaria, Falciparum/drug therapy , Pregnancy Complications/physiopathology , Adult , Drug Combinations , Female , Humans , Infant, Newborn , Malaria, Falciparum/complications , Malaria, Falciparum/parasitology , Malaria, Falciparum/physiopathology , Nigeria/epidemiology , Plasmodium falciparum/pathogenicity , Pregnancy , Pregnancy Complications/chemically induced , Pregnancy Complications/epidemiology , Pyrimethamine/adverse effects , Sulfadoxine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL